Search clinical trials for: Acarbose

Total 112 results

EMS

Completed

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Brazil
Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

Diabetes Mellitus, Type 2

Germany
Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg

Diabetes Mellitus, Type 2

Germany
Bayer

Completed

Bioequivalence Study for Acarbose / Metformin FDC

Diabetes Mellitus, Type II

Korea, Republic of
Guiyang Medical University

Not yet recruiting

Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

Head and Neck Squamous Carcinoma

China
Radboud University Medical Center

Completed

Vildagliptin and Endothelium-dependent Vasodilatation

Type 2 Diabetes | Endothelial Dysfunction

Netherlands
The Cleveland Clinic

Completed

Bexarotene Amyloid Treatment for Alzheimer's Disease (BEAT-AD)

Alzheimer's Disease

United States
The University of Texas Health Science Center at...

Completed

Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)

Aging

United States
GWT-TUD GmbH
Technische Universität Dresden; University of Regensburg; Diakonissen Krankenhaus...

Completed

AI(I)DA Acarbose and the Subclinical Inflammation

Type 2 Diabetes Mellitus | Subclinical Inflammation

Germany
GWT-TUD GmbH

Completed

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Metabolic Syndrome

Germany
Technische Universität Dresden

Completed

Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes
Aichi Gakuin University

Unknown

Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

Coronary Artery Disease | Diabetes Mellitus | Impaired Glucose Tolerance

Japan
AgelessRx

Completed

The Efficacy and Tolerability of Acarbose in Healthy Individuals

Tolerance | Side Effect | Glucose Response

United States
Bayer

Completed

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Diabetes Mellitus

Russian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
Karolinska Institutet
Bayer; The Swedish Research Council

Completed

Exercise and Acarbose in Type 2 Diabetes

Diabetes Mellitus Type 2

Sweden
Bayer

Completed

GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

Diabetes Mellitus

Korea, Republic of
Bayer

Completed

Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life Setting (CATERING)

Diabetes Mellitus

Poland
Bayer

Completed

Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease (ABDOMEN)

Diabetes Mellitus

Poland
University of Alabama at Birmingham

Not yet recruiting

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

Kidney Cancer

United States
Bayer

Completed

Special Drug Use Investigation of Glucobay OD

Diabetes Mellitus

Japan
Bayer

Completed

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

Diabetes Mellitus

Spain
Bayer

Completed

Diabetes Treatment With Glucobay in Combination With Metformin

Type 2 Diabetes Mellitus

India
Lotus Pharmaceutical

Unknown

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.

Taiwan
Bayer

Completed

Diabetes Treatment With Glucobay in Combination With Sulfonylurea

Type 2 Diabetes Mellitus

India
Inje University
Sanofi

Completed

The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients

Diabetes Mellitus | Type 2 Diabetes Mellitus

Korea, Republic of
He Xia

Unknown

Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma (NPC-RCT-WCRT)

Nasopharyngeal Carcinoma
Royan Institute

Completed

Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)

PCO

Iran, Islamic Republic of
Bayer

Active, not recruiting

A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D) (START-AM)

Type 2 Diabetes Mellitus

India
Hvidovre University Hospital
University of Copenhagen

Completed

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Overweight

Denmark
Bayer

Completed

GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients (GLOBE)

Type 2 Diabetes

India
Bayer

Withdrawn

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice (GLORY)

Diabetes Mellitus, Type 2
Bayer

Completed

Glucose Reduction by Early Acarbose Treatment in Basal Insulin (GREAN)

Diabetes Mellitus, Type 2

Korea, Republic of
The Catholic University of Korea
Bayer

Completed

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Type 2 Diabetes Mellitus

Korea, Republic of
Bayer

Completed

Bioequivalence Study for Acarbose/Metformin FDC

Diabetes Mellitus, Type 2

China
Astellas Pharma Inc

Terminated

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

Type II Diabetes Mellitus

Taiwan, Korea, Republic of
Novartis Pharmaceuticals

Completed

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (ENERGY)

Diabetes Mellitus, Type 2

China
Empros Pharma AB
CTC Clinical Trial Consultants AB

Completed

A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)

Overweight or Obesity

Sweden
Kenneth Madden

Completed

Acarbose and Older Adults With Postprandial Hypotension (PPH)

Syncope | Other Specified Hypotension

Canada
Sanofi

Completed

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)

Diabetes Mellitus, Type 2

China
Peking University

Unknown

Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients (VISA-T2DM)

Obesity | Diabetes Mellitus, Type 2

China
University of Minnesota

Completed

Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Hyperinsulinemic Hypoglycemia

United States
Population Health Research Institute
Hamilton Health Sciences Corporation

Completed

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Type 2 Diabetes Mellitus

Canada
University Hospital of Mont-Godinne

Unknown

Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning

Neurogenic Lung Edema

Belgium
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens (CORRECT)

Diabetic Retinopathy

China
Nanjing First Hospital, Nanjing Medical University

Completed

Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

Type 2 Diabetes

China
Wuhan General Hospital of Guangzhou Military Command

Completed

Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

Coronary Artery Disease | Newly Diagnosed Type 2 Diabetes

China
Gilead Sciences

Completed

Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Hepatitis C Virus Infection

Germany, United States, Australia, United Kingdom, Canada, France, New Zealand
Japan Early Diabetes Intervention Study Group

Unknown

Japan Early Diabetes Intervention Study (JEDIS)

Diabetes Mellitus

Japan
RenJi Hospital

Unknown

Research of Intensive Metabolic Intervention Before Pregnancy in PCOS (PCOS)

PCOS | Impaired Glucose Tolerance

China
Translational Research Center for Medical Innovation...
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan; Kobe City...

Completed

Acarbose and Secondary Prevention After Coronary Stenting

Glucose Metabolism Disorders | Coronary Artery Disease

Japan

3

Subscribe